Riluzole in Mild Alzheimer's Disease

Clinical trial NCT01703117 · COMPLETED

Trial details

NCT number: NCT01703117
Sponsor: Icahn School of Medicine at Mount Sinai
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2013-11-01
Primary completion: 2020-05-26
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.